Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?
作者信息
Picado Albert, Angheben Andrea, Marchiol Andrea, Alarcón de Noya Belkisyolé, Flevaud Laurence, Pinazo Maria Jesus, Gállego Montserrat, Meymandi Sheba, Moriana Silvia
机构信息
Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Centre for Tropical Diseases, Hospital Sacro Cuore, Don Calabria, Negrar, Verona, Italy.
出版信息
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005148. doi: 10.1371/journal.pntd.0005148. eCollection 2017 Jan.
Abstract
摘要
相似文献
1
Development of Diagnostics for Chagas Disease: Where Should We Put Our Limited Resources?恰加斯病诊断方法的发展：我们应将有限资源投向何处？
PLoS Negl Trop Dis. 2017 Jan 5;11(1):e0005148. doi: 10.1371/journal.pntd.0005148. eCollection 2017 Jan.
2
[Notes on rapid diagnostic tests for chronic Chagas disease].[慢性恰加斯病快速诊断检测的笔记]
Bull Soc Pathol Exot. 2017 Feb;110(1):9-12. doi: 10.1007/s13149-017-0546-6. Epub 2017 Jan 23.
3
Accuracy of a Rapid Diagnostic Test (Cypress Chagas Quick Test) for the Diagnosis of Chronic Chagas Disease in a Nonendemic Area: A Retrospective Longitudinal Study.在非流行地区用于诊断慢性恰加斯病的快速诊断检测（赛普拉斯恰加斯快速检测）的准确性：一项回顾性纵向研究
Am J Trop Med Hyg. 2017 Nov;97(5):1486-1488. doi: 10.4269/ajtmh.17-0205. Epub 2017 Aug 18.
4
Usefulness of the ARCHITECT Chagas assay as a single test for the diagnosis of chronic Chagas disease.ARCHITECT 克氏锥虫病检测法作为一种单项检测试验在慢性克氏锥虫病诊断中的效用。
Trop Med Int Health. 2018 Jun;23(6):634-640. doi: 10.1111/tmi.13063.
5
Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan.在日本临床环境中对 ARCHITECT 克氏锥虫病检测和内部 ELISA 进行优化和评估。
Parasitol Int. 2021 Feb;80:102221. doi: 10.1016/j.parint.2020.102221. Epub 2020 Oct 31.
6
Rapid diagnostic tests duo as alternative to conventional serological assays for conclusive Chagas disease diagnosis.快速诊断检测组合可作为确诊恰加斯病的传统血清学检测方法的替代方法。
PLoS Negl Trop Dis. 2017 Apr 3;11(4):e0005501. doi: 10.1371/journal.pntd.0005501. eCollection 2017 Apr.
7
Case report of Chagas disease reactivation: new diagnosis tool by direct microscopic observation of biopsy specimen and its preservation fluid.病例报告：克氏锥虫病再激活：通过直接显微镜观察活检标本及其保存液的新诊断工具。
Rev Soc Bras Med Trop. 2020 Dec 21;54:e20200326. doi: 10.1590/0037-8682-0326-2020. eCollection 2020.
8
Describing nearly two decades of Chagas disease in Germany and the lessons learned: a retrospective study on screening, detection, diagnosis, and treatment of Trypanosoma cruzi infection from 2000 - 2018.描述德国近 20 年的查加斯病及其经验教训：一项回顾性研究，研究了 2000-2018 年期间克氏锥虫感染的筛查、检测、诊断和治疗。
BMC Infect Dis. 2020 Dec 3;20(1):919. doi: 10.1186/s12879-020-05600-8.
9
Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.使用恰加斯尿液纳米颗粒检测（Chunap）与克氏锥虫/艾滋病毒合并感染患者的寄生虫血症水平进行关联分析。
PLoS Negl Trop Dis. 2016 Feb 26;10(2):e0004407. doi: 10.1371/journal.pntd.0004407. eCollection 2016 Feb.
10
Rapid Diagnostic Tests for Trypanosoma cruzi Infection: Field Evaluation of Two Registered Kits in a Region of Endemicity and a Region of Nonendemicity in Argentina.克氏锥虫感染的快速诊断检测：在阿根廷一个地方性流行区和一个非地方性流行区对两种已注册试剂盒进行现场评估
J Clin Microbiol. 2020 Nov 18;58(12). doi: 10.1128/JCM.01140-20.
引用本文的文献
1
Serological determination of Trypanosoma cruzi in northern region of the State of Mexico.墨西哥州北部地区克氏锥虫的血清学检测
Parasitol Res. 2025 Feb 18;124(2):23. doi: 10.1007/s00436-025-08464-6.
2
Prevalence and diagnostic accuracy of different diagnostic tests for Chagas disease in an indigenous community of the Paraguayan Chaco.巴拉圭查科地区一个原住民社区中不同诊断测试对恰加斯病的患病率及诊断准确性
PLoS Negl Trop Dis. 2025 Feb 7;19(2):e0012861. doi: 10.1371/journal.pntd.0012861. eCollection 2025 Feb.
3
Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay.使用血清学多重免疫测定法对恰加斯病患者治疗后抗体下降情况进行早期评估。
Nat Commun. 2024 Dec 3;15(1):10530. doi: 10.1038/s41467-024-54910-x.
4
The use of rapid diagnostic tests for chronic Chagas disease: An expert meeting report.慢性恰加斯病快速诊断检测的应用：一份专家会议报告。
PLoS Negl Trop Dis. 2024 Aug 8;18(8):e0012340. doi: 10.1371/journal.pntd.0012340. eCollection 2024 Aug.
5
Persistent Biofluid Small-Molecule Alterations Induced by Infection Are Not Restored by Parasite Elimination.感染引起的持续性生物流体小分子改变不能通过寄生虫消除来恢复。
ACS Infect Dis. 2023 Nov 10;9(11):2173-2189. doi: 10.1021/acsinfecdis.3c00261. Epub 2023 Oct 26.
6
Persistent biofluid small molecule alterations induced by infection are not restored by antiparasitic treatment.感染引起的生物流体小分子持续改变不会通过抗寄生虫治疗恢复。
bioRxiv. 2023 Jun 3:2023.06.03.543565. doi: 10.1101/2023.06.03.543565.
7
Accuracy of Diagnostic Tests for the Detection of Chagas Disease: A Systematic Review and Meta-Analysis.用于检测恰加斯病的诊断测试的准确性：一项系统评价和荟萃分析。
Diagnostics (Basel). 2022 Nov 10;12(11):2752. doi: 10.3390/diagnostics12112752.
8
Chagas Disease in Pregnant Women from Endemic Regions Attending the Hospital General de Mexico, Mexico City.来自墨西哥城墨西哥总医院所在流行地区的孕妇中的恰加斯病
Trop Med Infect Dis. 2022 Jan 11;7(1):8. doi: 10.3390/tropicalmed7010008.
9
Multi-criteria decision analysis approach for strategy scale-up with application to Chagas disease management in Bolivia.多准则决策分析方法在战略扩展中的应用——以玻利维亚恰加斯病管理为例。
PLoS Negl Trop Dis. 2021 Mar 26;15(3):e0009249. doi: 10.1371/journal.pntd.0009249. eCollection 2021 Mar.
10
Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus.恰加斯病患者治疗疗效早期评估检测的目标产品概况：专家共识
PLoS Negl Trop Dis. 2020 Apr 23;14(4):e0008035. doi: 10.1371/journal.pntd.0008035. eCollection 2020 Apr.
本文引用的文献
1
Chagas' Disease.恰加斯病
N Engl J Med. 2015 Jul 30;373(5):456-66. doi: 10.1056/NEJMra1410150.
2
Target Product Profile (TPP) for Chagas Disease Point-of-Care Diagnosis and Assessment of Response to Treatment.恰加斯病即时诊断及治疗反应评估的目标产品概况（TPP）
PLoS Negl Trop Dis. 2015 Jun 4;9(6):e0003697. doi: 10.1371/journal.pntd.0003697. eCollection 2015 Jun.
3
Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review.用于评估恰加斯病治疗效果的生物学标志物：系统评价。
Expert Rev Anti Infect Ther. 2014 Apr;12(4):479-96. doi: 10.1586/14787210.2014.899150.
4
Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.恰加斯病、人类非洲锥虫病和利什曼病的研究重点。
World Health Organ Tech Rep Ser. 2012(975):v-xii, 1-100.
5
Chronic phase of Chagas disease: why should it be treated? A comprehensive review.恰加斯病慢性期：为何应该进行治疗？全面综述。
Mem Inst Oswaldo Cruz. 2011 Sep;106(6):641-5. doi: 10.1590/s0074-02762011000600001.
6
Chagas disease.恰加斯病。
Lancet. 2010 Apr 17;375(9723):1388-402. doi: 10.1016/S0140-6736(10)60061-X.
7
Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?恰加斯病的诊断：已经取得了哪些成就？在诊断和随访研究方面还有哪些需要做的？
Mem Inst Oswaldo Cruz. 2009 Jul;104 Suppl 1:115-21. doi: 10.1590/s0074-02762009000900017.
8
New, improved treatments for Chagas disease: from the R&D pipeline to the patients.恰加斯病的新型改良疗法：从研发流程到患者
PLoS Negl Trop Dis. 2009 Jul 7;3(7):e484. doi: 10.1371/journal.pntd.0000484.
9
International meeting: new diagnostic tests are urgently needed to treat patients with Chagas disease.国际会议：治疗恰加斯病患者急需新的诊断测试。
Rev Soc Bras Med Trop. 2008 May-Jun;41(3):315-9. doi: 10.1590/s0037-86822008000300020.
Zotero 插件